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Distinct types of GABAergic interneurons target different subcellular domains of pyramidal cells, thereby shaping pyramidal cell activity
patterns. Whether the presynaptic heterogeneity of GABAergic innervation is mirrored by specific postsynaptic factors is largely unex-
plored. Here we show that dystroglycan, a protein responsible for the majority of congenital muscular dystrophies when dysfunctional,
has a function at postsynaptic sites restricted to a subset of GABAergic interneurons. Conditional deletion of Dag1, encoding dystrogly-
can, in pyramidal cells caused loss of CCK-positive basket cell terminals in hippocampus andneocortex. PV-positive basket cell terminals
were unaffected in mutant mice, demonstrating interneuron subtype-specific function of dystroglycan. Loss of dystroglycan in pyrami-
dal cells had little influence on clustering of other GABAergic postsynaptic proteins and of glutamatergic synaptic proteins. CCK-positive
terminals were not established at P21 in the absence of dystroglycan andweremarkedly reducedwhen dystroglycanwas ablated in adult
mice, suggesting a role for dystroglycan in both formation and maintenance of CCK-positive terminals. The necessity of neuronal
dystroglycan for functional innervation by CCK-positive basket cell axon terminals was confirmed by reduced frequency of inhibitory
events in pyramidal cells of dystroglycan-deficient mice and further corroborated by the inefficiency of carbachol to increase IPSC
frequency in these cells. Finally, neurexin binding seems dispensable for dystroglycan function because knock-in mice expressing
binding-deficient T190Mdystroglycan displayed normal CCK-positive terminals. Together, we describe a novel function of dystroglycan
in interneuron subtype-specific trans-synaptic signaling, revealing correlation of presynaptic and postsynaptic molecular diversity.
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Introduction
GABAergic interneurons, which provide the main source of in-
hibitory drive in the adult mammalian brain, form several
distinct classes according to morphological, molecular, and func-
tional criteria (Fishell and Rudy, 2011). This specialization allows
interneurons to adapt to different demands of postsynaptic tar-
gets and thereby control membrane excitability in a spatially and
temporally precise manner (Klausberger and Somogyi, 2008).
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Significance Statement
Dystroglycan, an extracellular and transmembrane protein of the dystrophin-glycoprotein complex, is at the center of molecular
studies of muscular dystrophies. Although its synaptic distribution in cortical brain regions is long established, function of
dystroglycan in the synapse remained obscure. Usingmice that selectively lack neuronal dystroglycan, we provide evidence that a
subset of GABAergic interneurons requires dystroglycan for formation andmaintenance of axonal terminals on pyramidal cells.
As such, dystroglycan is the first postsynaptic GABAergic protein for which an interneuron terminal-specific function could be
shown. Our findings also offer a new perspective on the mechanisms that lead to intellectual disability in muscular dystrophies
without associated brain malformations.
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Most interneuron classes innervate only a specific subcellular
domain of target cells, for example, the axon initial segment, the
cell soma, or dendritic regions. Synaptic transmission from dif-
ferent interneuron subtypes has thus fundamentally different
impact on the activity of postsynaptic cells. It might be advanta-
geous to account for this diversity of GABAergic innervation with
postsynaptic specializations matching the specific properties and
plasticity mechanisms of synaptic terminals they are contacted
from. Indeed, the GABAergic postsynaptic density (PSD) is char-
acterized by a large molecular heterogeneity (Tyagarajan and
Fritschy, 2014). However, little is known about such subtype-
specific postsynaptic GABAergic adaptations.
Basket cells are GABAergic interneurons that specifically tar-
get the perisomatic region of principal neurons. In cerebral
cortex and hippocampus, expression of parvalbumin (PV) or
cholecystokinin (CCK) identifies basket cells as belonging to one
of two nonoverlapping groups (Freund and Katona, 2007). Al-
though these two interneuron subtypes innervate the same sub-
cellular domain, they are distinguished by various traits (Bartos
and Elgueta, 2012). Only CCK-positive basket cells express pre-
synaptic cannabinoid receptors, enabling retrograde signaling of
endocannabinoids to suppress GABA release. Different firing
patterns, expression profiles, and developmental origins further
set the two subtypes apart. Therefore, it is conceivable that the
two types of basket cells use different mechanisms for synapse
formation and require a different set of postsynaptic proteins to
exert their vastly different functions.
Dystroglycan (DG) is the central component of the
dystrophin-glycoprotein complex (DGC). The extracellular
-DG and transmembrane-DG, generated by proteolytic cleav-
age of a single gene product, bind the large cytoplasmic protein
dystrophin, which in turn can interact with actin filaments.
-DG, through its glycosyl side chains, can bind to extracellular
matrix components. The crucial role of the DGC in muscle tissue
was revealed by mutations affecting DGC components that lead
to muscular dystrophies (McNally and Pytel, 2007). The DGC,
albeit differing slightly in its molecular composition, is also ex-
pressed in the CNS by glial cells and neurons (Waite et al., 2012).
Developmental brain malformations and intellectual disability,
observed frequently in muscular dystrophies caused by DGC dys-
function, testify to the importance of this complex for brain func-
tion. The finding that the DGC is present in pyramidal cells as
large, mostly perisomatic clusters postsynaptic to GABAergic ter-
minals spurred interest in the synaptic function of the DGC (Li-
dov et al., 1990). Because reduced GABAAR immunoreactivity
was found in a mouse model of Duchenne’s muscular dystrophy
(DMD), a function for the DGC in clustering of PSD components
was posited (Knuesel et al., 1999; Vaillend et al., 2010). Despite
the selective DGC subcellular distribution, biochemical interac-
tion with presynaptic neurexins and the obligatory association of
DG with GABAergic presynaptic terminals in neuronal cultures,
the role of the DGC in trans-synaptic signaling was never system-
atically assessed (Sugita et al., 2001; Bru¨nig et al., 2002).
We hypothesized that the diversity of GABAergic PSD com-
position is functionally related to the heterogeneity of GABAergic
innervation. Because of its restricted distribution and known role
as a transmembrane complex, DG seemed ideally suited to ad-
dress this issue. Ablation of DG specifically in pyramidal neurons
allowed us to study the synaptic function of the DGC without
confounding deficits in neuronal migration associated with loss
of DG in other tissues. Using this approach, we demonstrate that
the neuronal DGC plays an essential role in trans-synaptic signal-
ing necessary for formation and maintenance of functional axon
terminals from CCK-positive basket cells. Because the neuronal
circuits depending on this signaling have been shown to be in-
volved in major cognitive functions, our findings open new ave-
nues in identifying the causes of intellectual disability in muscular
dystrophies.
Materials andMethods
Animals. All mice were bred on C57BL/6 background at the Laboratory
Animal Service Center (Schlieren, Zurich, Switzerland) and kept in stan-
dard housing with food and water provided ad libitum. Mice harboring
loxP sites in exon 2 of Dag1 were obtained from The Jackson Laboratory.
NEX-Cre transgenic mice were used to achieve selective ablation of neu-
ronal DG (Goebbels et al., 2006) and were provided by Dr. Sandra Goe-
bbels (Max-Planck-Institute of Experimental Medicine, Goettingen,
Germany). Dag1 T190M knock-in mice were provided by Dr. Kevin P.
Campbell (Howard Hughes Medical Institute, Iowa City, IA). Dag1
floxed mice were genotyped by PCR analysis using primers 5-
GGAGAGGATCAATCATGG-3 and 5-CAACTGCTGCATCTCTAC-
3. Genotyping of NEX-Cre transgenic mice was performed as described
previously (Goebbels et al., 2006). To obtain DG cKO and control mice,
NEX-Cre tg//Dag1 loxP/ mice were bred to NEX-Cre//Dag1 loxP/loxP
mice. All experiments were approved by the veterinary office of the
Canton of Zurich.
Western blotting. Adult DG cKO and control mice of both sexes were
anesthetized with pentobarbital (Nembutal; 50 mg/kg i.p.) and killed by
decapitation. Cheek muscle was dissected on ice and transferred to lysis
buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 1% Triton X-100, Complete
Mini Protease Inhibitor Mixture, Roche). Tissue was Dounce homoge-
nized, sonicated, and incubated on ice for 1 h. Lysates were centrifuged at
50,000 RPM for 1 h at 4°C, and supernatants were stored at80°C. For
anti--DG blots, glycosylated proteins were enriched by incubating ly-
sates with wheat germ agglutinin agarose beads (Vector Labs) at 4°C
overnight. Proteins were eluted with 300 mM N-acetyl-glucosamine and
stored at 20°C. Laemmli buffer was added to wheat germ agglutinin-
enriched and nonenriched lysates (for loading control) and samples were
run on 8% Tris-glycine polyacrylamide gels. Proteins were transferred to
PVDF membranes. Mouse anti--DG (11H6C4; Millipore; 1:1000) and
rabbit anti-actin (Sigma; 1:5000) antibodies were incubated in Tris-
buffered saline with 0.05% Tween 20 (TBST), including 5% Western
Blocking Solution (Roche) overnight at 4°C. Membranes were washed 5
times in TBST. HRP-coupled donkey secondary antibodies (1:20,000)
were incubated for 1 h at room temperature, and membranes were
washed again 5 times in TBST. SuperSignal West Pico Chemiluminescent
Substrate (Thermo Fisher Scientific) was applied, and membranes were
developed on x-ray film (Fujifilm).
Tissue preparation for immunohistochemistry. DG cKO and control
mice of both sexes at the age of 8 –12 weeks were anesthetized by
intraperitoneal pentobarbital injection (Nembutal; 50 mg/kg) and
perfused transcardially with ice-cold oxygenated ACSF, pH 7.4, for 2
min, as described previously (Notter et al., 2014). Brains were imme-
diately dissected and fixed in 4% PFA for 100 min on ice. After rinsing
in PBS, brains were incubated in 30% sucrose (in PBS) at 4°C over-
night. The 50-m-thick coronal sections were cut from frozen blocks
using a sliding microtome (HM400; Microm) and stored at20°C in
antifreeze solution. Tissue preparation from P21 mice followed the
same protocol with the following modifications: Mice were perfused
with 4% PFA (after brief perfusion with PBS to rinse blood), and
brains were postfixed for 3 h.
Immunohistochemistry. After rinsing once in PBS, sections were incu-
bated in primary antibody solution (50 mM Tris, 150 mM NaCl, 0.2%
Triton X-100, 2% normal goat serum, pH 7.4) with antibodies listed in
Table 1. Primary antibodies were incubated at 4°C overnight, or for 3 d if
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DG or dystrophin was labeled. Sections were washed 3 times for 10 min
in PBS and incubated in secondary antibody solution (50 mM Tris, 150
mM NaCl, 0.05% Triton X-100, 2% normal goat serum, pH 7.4) for 30
min at room temperature with secondary antibodies raised in goat. An-
tibodies conjugated to AlexaFluor-488 and AlexaFluor-647 (Invitrogen)
were diluted 1:1000, whereas antibodies conjugated to Cy3 (Jackson Im-
munoResearch Laboratories) were diluted 1:500. Sections were washed 3
times for 10 min in PBS and mounted on gelatin-coated slides using
Fluorescence Mounting Medium (Dako). For immunoperoxidase stain-
ings, biotinylated secondary antibodies were diluted 1:300. After washing
3 times for 10 min in PBS, sections were incubated with avidin-
peroxidase-complex solution (Vector Labs) for 30 min at room temper-
ature and washed again 3 times for 10 min in PBS. Sections were
preincubated in DAB solution (50 mM Tris, 150 mM NaCl, 0.05% Triton
X-100, 0.5 g/L DAB, pH 7.7) for 5 min under agitation and DAB solution
containing 0.01% H2O2 was added to sections. The reaction was stopped
by washing in ice-cold PBS several times. Sections were mounted on
gelatinized slides and dried overnight. After dehydration by immersion
in increasingly concentrated ethanol solutions and clearing in xylene,
slides were coverslipped with Eukitt (Merck).
Stereology. Immunoreactive cells were counted and the size of
the dorsal hippocampus estimated with the help of Mercator software
(Explora Nova). Four equidistant coronal sections per mouse were
used to count cells in all layers of the hippocampus proper. The
volume was estimated using Mercator software, and cell density was
calculated.
Image acquisition and statistical analysis. z-stack images (3 optical sec-
tions, 0.5 m step size) were recorded of all specimens using confocal
laser scanning microscopy (LSM 700, Carl Zeiss). Images were taken
using a 40 objective with a numerical aperture of 1.4 and had a pixel
size of 112 112 nm 2. To reduce variability, 3 or 4 sections were imaged
per mouse and cluster density values were averaged from these sections.
All imaging parameters were kept constant between genotypes. For clus-
ter analysis, maximum intensity projections were created from z-stacks
and analyzed using ImageJ (National Institutes of Health). Representa-
tive example images were processed with Imaris (Bitplane). Statistical
tests were performed using Prism software (GraphPad). A minimum of 4
mice per group were used and statistical tests were performed using data
points from individual mice for density values and using pooled cluster
data from all mice per group for size (Tables 2, 3).
Stereotactic injections. Eight- to 10-week-old mice transgenic for loxP
in exon 2 of Dag1 were anesthetized with isoflurane (Attane; Piramal).
After mice were head-fixed on a stereotactic frame (David Kopf Instru-
ments), a small longitudinal incision was made under continuous ad-
ministration of isoflurane to reveal the skull. Bregma was identified, and
the skull was perforated unilaterally using a surgical drill at the following
coordinates relative to bregma: x  1.9 mm, y  1.6 mm. A glass
pipette filled with virus solution was inserted into the brain to z  1.5
mm. A total of 1 l virus solution was injected using an automated
injection pump in increments of 70 nl over 10 min. The pipette was
removed and the incision sutured. Mice were injected intraperitoneally
with 1 mg/kg buprenorphine (Temgesic; Essex Chemicals) and placed on
a warm pad for recovery before returning to the home cage.
Virus. AAV8-CaMKIIa-mCherry-Cre (dot blot titer 4.7  10 12 VG/
ml) was purchased from the University of North Carolina Vector Core
(Chapel Hill, NC).
Acute brain slice preparation. Five- to 6-week-old DG cKO and control
mice were briefly anesthetized with isoflurane and decapitated. The brain
was quickly removed and transferred to ice-cold solution containing 65
mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7 mM
MgCl2, 0.5 mM CaCl2, 25 mM glucose, and 105 mM sucrose saturated with
95% O2 and 5% CO2. The 350-m-thick transverse slices containing the
hippocampus were cut from the tissue block with a vibratome (Microm
HM 650V, Thermo Scientific) and kept in oxygenated ACSF (315
mOsm) containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25
mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2, and 25 mM glucose at 34°C for
25 min and then at room temperature until use.
Electrophysiology and data analysis. For recording, individual slices
were transferred to a recording chamber perfused with oxygenated ACSF
solution (same as above) at a flow rate of 1–2 ml/min. Whole-cell record-
ings were made from hippocampal CA1 pyramidal neurons. Cells were
first selected using oblique IR illumination with a BX51 microscope
(40 water-immersion objective; Olympus). Subsequently, neurons
were anatomically identified using a fluorescent dye (Alexa-488, 10 M)
included in the intracellular solution. The dye was excited with wLS
broad-band LED illumination (488 nm), and images were acquired with
Retiga R1 camera using Ocular software (Qimaging). The cells were
patched with borosilicate glass pipettes (2–5 M) containing the follow-
ing: 135 mM KCl, 10 mM HEPES, 10 mM sodium phosphocreatine, 4 mM
Mg-ATP, 0.3 mM Na-GTP, pH 7.3 with KOH. Recordings were per-
Table 1. Antibodies used for immunohistochemical stainingsa
Target Host species Dilution Catalog # Company/origin
-Dystroglycan (VIA4–1) Mouse 1:100 05-298 EMD Millipore
-Dystroglycan (11H6C4) Mouse 1:100 05-593 EMD Millipore
-Dystroglycan Mouse 1:100 ab49515 Abcam
Bassoon Mouse 1:2000 VAM-PS003 StressGen
CB1 Rabbit 1:3000 258003 Synaptic Systems
Cholecystokinin 8 Mouse 1:1000 ab37274 Abcam
Cre recombinase Rabbit 1:1000 PRB-106C Covance
Dystrophin (C-terminal) Mouse 1:100 BT39-9050-05 Biotrend
GABAAR 1 subunit Guinea pig 1:20,000 — Fritschy and Mohler, 1995
GABAAR 2 subunit Guinea pig 1:6000 — Fritschy and Mohler, 1995
GABAAR 2 subunit Guinea pig 1:10,000 — Fritschy and Mohler, 1995
GAD65/67 Rabbit 1:2000 GC3008 Biomol
Gephyrin Mouse 1:1000 147021 Synaptic Systems
NeuN Mouse 1:1000 MAB377 Chemicon
NL2 Rabbit 1:10,000 — Gift from Dr. Peter Scheiffele
PV Rabbit 1:1000 24428 ImmunoStar
PSD-95 Mouse 1:1000 MA1-045 ABR
Synaptotagmin 2 Rabbit 1:1000 105123 Synaptic Systems
synArfGEF Guinea pig 1:3000 — Gift from Dr. Hiroyuki Sakagami
(Fukaya et al., 2011)
VGAT Rabbit 1:3000 131003 Synaptic Systems
VGluT1 Guinea pig 1:1000 135304 Synaptic Systems
VGluT3 Guinea pig 1:4000 AB5421 Merck Millipore
aIf not otherwise stated, antibody VIA4–1 was used to label-dystroglycan. For secondary antibodies, see Materials and Methods.
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formed using Multiclamp 700B amplifier, and data were acquired with a
Digidata 1550A 16-bit board (all from Molecular Devices). All experi-
ments were performed at room temperature. Spontaneous IPSCs
(sIPSC) were recorded from CA1 pyramidal cells clamped at a membrane
voltage of 70 mV in the presence of 10 M NBQX to block excitatory
transmission. Recordings with unstable baseline or400 pA were re-
jected. Currents were filtered off-line using a Butterworth low-pass filter
(2 kHz) and analyzed in 1 or 2 min bins using the Mini-Analysis Program
6.0.7 (Synaptosoft). For pharmacology, baseline was analyzed 2 min be-
fore the application of carbachol (CCh, 10 M). To study the effect of
CCh, 1–2 min bins were analyzed at least 8 min following the arrival of
CCh into the bath. Recordings with leak increasing100 pA and access
resistance changing 30% between the beginning and the end of the
recording were discarded. At least 100 events were analyzed for any con-
dition in any experiment. Events were identified as sIPSC by setting the
event detection threshold at least twofold the baseline noise level and by
checking that events had (1) rise times faster than the decay time, (2) rise
times0.5 ms, and (3) decay times1.5 ms. Events not fitting the above
parameters were rejected. Event amplitudes, interevent intervals (IEIs),
and rise and decay times were first averaged within each experiment and
regrouped by condition. The frequencies were calculated from the IEIs,
and the resulting means were averaged between experiments. Single-cell
properties (access resistance, membrane capacitance, etc.) were analyzed
with Clampfit 10.5 (Axon Instruments). Graphs were done using Igor
6.37 software (Wavemetrics) and Illustrator 15.1.0 (Adobe).
Results
Use of NEX-Cre driver line for pyramidal cell-specific
DG ablation
To study the role of neuronal DGC in the brain without gross mor-
phological alterations, it is necessary to target DG in neurons but
spare glial DG. For this reason, mice harboring loxP sites in Dag1
were crossed to the NEX-Cre driver line, which exhibits an exclu-
sively neuronal Cre recombinase expression pattern (Goebbels et al.,
2006; Satz et al., 2010). In hippocampus and neocortex, NEX
promoter-mediated Cre expression is restricted to pyramidal cells,
the cell type displaying most prominent DG expression in the fore-
Table 2. Results of statistical tests performed for immunohistochemical stainingsa
Epitope Condition Unpaired t test (density) Kolmogorov–Smirnov test (size)
GABAAR 1 subunit DG cKO/adult/CA1 t(6) 0.920, p 0.393 n 33385, D 12.662, p	 0.001
GABAAR 2 subunit DG cKO/adult/CA1 t(15) 3.816, p 0.002 n 18495, D 3.484, p	 0.001
GABAAR 2 subunit DG cKO/adult/CA1 t(7) 1.607, p 0.152 n 31807, D 3.692, p	 0.001
Gephyrin DG cKO/adult/CA1 t(7) 1.252, p 0.251 n 39289, D 0.720, p 0.677
NL2 DG cKO/adult/CA1 t(6) 0.979, p 0.366 n 32217, D 5.476, p	 0.001
synArfGEF DG cKO/adult/CA1 t(6) 1.093, p 0.316 n 22737, D 3.850, p	 0.001
VGAT DG cKO/adult/CA1 t(15) 0.646, p 0.528 n 20569, D 0.528, p 0.943
DG cKO/adult/neocortex t(9) 1.309, p 0.223 n 24713, D 1.107, p 0.172
PV DG cKO/adult/CA1 t(7) 0.198, p 0.849 n 24929, D 1.068, p 0.204
DG cKO/adult/neocortex t(9) 0.454, p 0.661 n 20534, D 4.845, p	 0.001
DG cKO/P21/CA1 t(8) 0.869, p 0.410 n 8010, D 1.037, p 0.233
CB1 DG cKO/adult/CA1 t(6) 16.869, p	 0.001 n 4654, D 4.325, p	 0.001
DG cKO/adult/neocortex t(11) 7.117, p	 0.001 n 8067, D 6.960, p	 0.001
T190M/adult/CA1 t(8) 0.681, p 0.515 n 9152, D 0.881, p 0.420
Synaptotagmin 2 DG cKO/adult/CA1 t(9) 1.456, p 0.179 n 3397, D 1.977, p 0.001
Cholecystokinin 8 DG cKO/adult/CA1 t(17) 6.292, p	 0.001 n 5111, D 4.133, p	 0.001
DG cKO/adult/neocortex t(6) 4.475, p 0.004 n 1387, D 1.874, p 0.002
PSD-95 DG cKO/adult/CA1/SP t(6) 1.106, p 0.311 n 16281, D 1.554, p 0.016
DG cKO/adult/CA1/SR t(6) 0.243, p 0.817 —
Bassoon DG cKO/adult/CA1/SP t(10) 0.767, p 0.461 n 32489, D 2.275, p	 0.001
DG cKO/adult/CA1/SR t(10) 0.871, p 0.404 —
VGluT1 DG cKO/adult/CA1 t(6) 0.094, p 0.928 n 12776, D 0.492, p 0.969
VGluT3 DG cKO/adult/CA1 t(21) 13.213, p	 0.001 n 5975, D 8.273, p	 0.001
DG cKO/adult/neocortex t(9) 0.456, p 0.659 n 6523, D 2.054, p	 0.001
DG cKO/P21/CA1 t(8) 13.437, p	 0.001 n 1830, D 8.270, p	 0.001
T190M/adult/CA1 t(8) 0.494, p 0.634 n 4763, D 0.702, p 0.708
aNumbers in subscript in t test represent degrees of freedom. D represents test statistics for Kolmogorov–Smirnov tests.
Table 3. Results of statistical tests performed for immunohistochemical stainings of injected tissuea
Condition
t test (unpaired between genotypes,
paired between hemispheres; density)
Kruskal–Wallis
test (size)
Dunn’s multiple comparison
test (size)
28 dpi/loxP/ t(3) 0.520, p 0.639 n 13610 y 283.498, p	 0.05
28 dpi/loxP/loxP t(4) 2.895, p 0.044 H 55.796 y 539.294, p	 0.001
28 dpi/contralateral t(7) 1.032, p 0.336 p	 0.001 y 136.188, p 0.05
28 dpi/ipsilateral t(7) 2.894, p 0.023 y 391.984, p	 0.001
42 dpi/loxP/ t(4) 0.870, p 0.434 n 9915 y 93.906, p 0.05
42 dpi/loxP/loxP t(4) 3.478, p 0.025 H 87.162 y 693.091, p	 0.001
42 dpi/contralateral t(8) 1.040, p 0.329 p	 0.001 y 82.049, p 0.05
42 dpi/ipsilateral t(8) 4.059, p 0.004 y 681.234, p	 0.001
84 dpi/loxP/ t(5) 1.843, p 0.125 n 7378 y 16.550, p 0.05
84 dpi/loxP/loxP t(3) 8.578, p 0.003 H 52.415 y 466.868, p	 0.001
84 dpi/contralateral t(8) 0.682, p 0.515 p	 0.001 y 143.428, p 0.05
84 dpi/ipsilateral t(8) 3.495, p 0.008 y 593.745, p	 0.001
aNumbers in subscript in t test represent degrees of freedom. H and y represent test statistics for Kruskal–Wallis tests and Dunn’s multiple comparison tests, respectively.
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brain. DG conditional knock-out mice (cKO; NEX-CreTg/,
Dag1 loxP/loxP) showed reduced size compared with control mice
(NEX-CreTg/, Dag1 loxP/; Fig. 1A). The smaller size was reflected
in reduced body and brain weight (Fig. 1B,C; 25.3
 1.0 g [mean

SEM] vs 18.7
 1.0 g, t(28) 4.670, p	 0.001 and 473.1
 5.4 mg vs
436.4
 6.5 mg, t(28) 4.381, p	 0.001, unpaired t tests). Although
cKO mice were born in Mendelian proportions, in adulthood less
than the expected 25% cKO were observed due to higher lethality of
cKO mice (Fig. 1D). To exclude a contribution of muscular dystro-
phy to this phenotype because of Cre leakage in muscle cells, -DG
levels were examined by Western blotting of wheat germ agglutinin-
enriched muscle proteins. cKO mice showed similar levels of muscle
-DG as control mice (Fig. 1E). As reported before, DG cKO mice
retained proper lamination of hippocampus (Fig. 1F) and neocortex
(Fig. 1G) according to NeuN and DAPI labeling (Satz et al., 2010).
Cre expression was restricted to pyramidal cells in hippocampus and
neocortex and was not detected in dentate gyrus granule cells of
adult mice (Fig. 1F,G) (Goebbels et al., 2006).
Efficiency and specificity of DG ablation were examined im-
munohistochemically in relevant brain regions. -DG, -DG,
and dystrophin can be detected immunohistochemically in large
perisomatic clusters in CA1 pyramidal cells (Fig. 2A) (Lidov et al.,
Figure 1. Characterization of NEX-Cre/Dag1 conditional KOmice.A, Representative examples of NEX-Cre Tg//Dag1 loxP/ (control) andNEX-Cre Tg//Dag1 loxP/loxP (cKO)mice (4months of age,
siblings, both female). B, cKO mice exhibit reduced body weight compared with sibling control mice. C, Wet brain weight was lower in cKO mice than in controls. D, cKO mice exhibited a higher
mortality rate than control mice, resulting in a frequency of cKOmice lower than the expected 25% at the age of 10 weeks. E, Similar levels of-DG isolated from cheekmuscle were found for cKO
and control mice. F, Cre expression was restricted to pyramidal cells in the hippocampus of cKO and control mice. In adult mice, dentate gyrus granule cells were not immunoreactive for Cre
recombinase. NeuN and DAPI labeling shows intact neuronal migrationwhen NEX-Cre is used as driver line to ablate Dag1.G, In primary somatosensory cortex, Cre expressionwas also restricted to
pyramidal cells. No migratory deficits were found in the neocortex in cKO mice. ***p	 0.001.
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1990; Knuesel et al., 1999). This characteristic immunolabeling was
absent in DG cKO mice for DG and to the same extent for dystro-
phin, showing that dystrophin needs DG for synaptic clustering in
vivo. In neocortex, perisomatic distribution of -DG, -DG, and
dystrophin was replaced by diffuse unspecific staining in neuropil in
DG cKO mice (Fig. 2B). Astrocyte endfeet are labeled prominently
by antibodies to -DG and dystrophin, and this labeling was pre-
served in DG cKO mice, as expected from neuron-specific Cre ex-
pression (Fig. 2A,B, asterisks). -DG immunolabeling in dentate
gyrus granule cells showed the same clustered distribution in both
genotypes (Fig. 2C). The transient NEX promoter activity in these
cells during early postnatal development might not be sufficient to
achieve recombination (Goebbels et al., 2006). Alternatively, loss of
DG during early development might be of little consequence in
adulthood because of DG expression by granule cells that were born
later. To further demonstrate specificity of NEX-induced DG abla-
tion, striatum was selected as a control region. As expected, the char-
acteristic sparse -DG labeling persisted in striatum of DG cKO
mice (Fig. 2D).
Loss of neuronal DG results in minor alterations in
GABAergic PSD protein clustering
Dependence of GABAergic PSD proteins on the DGC for synap-
tic clustering was suggested because of the subcellular localiza-
tion of the DGC, its molecular interactions, and because a
reduction in GABAAR clustering was observed in mice lacking
Figure 2. NEX-Cre-mediated ablation of dystroglycan (DG) leads to specific loss of dystrophin-glycoprotein complex in pyramidal cells. A, Characteristic staining of- and-DG and
dystrophin around CA1 pyramidal layer is lost in cKO mice. Labeling of -DG and dystrophin in astrocyte endfeet is retained in cKO mice (asterisks). B, In primary somatosensory cortex
layer 2/3, clustered labeling of DGC components around pyramidal cells is replaced by diffuse staining in the neuropil. Astrocyte endfeet labeling of -DG and dystrophin is retained in
cKO mice (asterisks). C, -DG immunofluorescence in dentate gyrus is unaffected by NEX-Cre-mediated ablation of DG. D, -DG expression in striatum is unaffected in cKO mice,
confirming specificity of NEX-Cre expression to pyramidal cells. SR, Stratum radiatum; SP, stratum pyramidale; ML, molecular layer; GCL, granule cell layer.
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Figure 3. Loss of neuronal dystroglycan does not prohibit formation of GABAergic PSD but leads to minor changes in GABAAR subunit clustering. A–C, Triple immunofluorescence labeling of
GABAergic postsynaptic markers in pyramidal layer of hippocampus CA1 area. The DGC is largely colocalized with 2 subunit and VGAT (A; arrowheads) but also with 1 subunit and NL2
(B; arrowheads). A minority of DGC clusters is not associated with GABAergic markers (A, B; arrows). D–H, Quantification of postsynaptic GABAergic markers (Figure legend continues.)
10302 • J. Neurosci., October 5, 2016 • 36(40):10296–10313 Fru¨h et al. • Dystroglycan Function at CCK-Positive Terminals
full-length dystrophin (Knuesel et al., 1999; Sumita et al., 2007;
Waite et al., 2012). However, a requirement of DG for clustering
of GABAergic postsynaptic proteins was never systematically
tested in vivo. We hypothesized that loss of neuronal DG affects
neuroligin 2 (NL2) clustering, which might be important for
clustering of GABAARs at perisomatic synapses through its inter-
action with gephyrin (Poulopoulos et al., 2009; Panzanelli et al.,
2011). DG cKO and control mice were analyzed for changes in
clustering of these markers in CA1 pyramidal layer. As previously
reported (Knuesel et al., 1999; Bru¨nig et al., 2002; Le´vi et al.,
2002), extensive colocalization of -DG and dystrophin was ob-
served with GABAergic markers, with a minority of DGC clusters
showing no colocalization (Fig. 3A,B; arrowheads and arrows,
respectively). Visual examination of GABAergic markers re-
vealed no obvious differences between genotypes (Fig. 3A–C).
However, quantification of cluster density and size showed a sig-
nificant decrease of GABAAR 1 subunit size in cKO accompa-
nied by an increase of GABAAR 2 subunit density (Fig. 3D,F).
No changes were observed in GABAAR 2 subunit and gephyrin
clustering (Fig. 3E,H), indicating that total synaptic GABAAR
content might be unchanged, whereas  subunit composition is
altered by loss of DG. Surprisingly, NL2 clustering was barely
affected in cKO mice, showing no difference in density and only a
slight but significant reduction in cluster size (Fig. 3G). Neuronal
DGC is also dispensable for normal colocalization of GABAAR2
subunit with gephyrin and of 1 subunit with NL2 (Fig. 3I).
Furthermore, dystrophin was suggested to be important for an-
choring synArfGEF at GABAergic PSDs (Fukaya et al., 2011).
Although dystrophin clustering is lost in DG cKO mice, synArf-
GEF distribution remained almost unchanged in CA1 pyramidal
layer of cKO mice (Fig. 3J).
Neuronal DG ablation leads to selective loss of markers of
CCK-positive basket cell terminals
Many binding partners of -DG have been identified, among
them the presynaptic neurexins (Sugita et al., 2001). Together
with the observation that DG is always apposed to GABAergic
presynaptic terminals in primary neuronal culture, a trans-
synaptic function for DG seemed probable (Bru¨nig et al., 2002).
We therefore probed DG cKO and control brain tissue with
antibodies to presynaptic GABAergic markers. Perisomatic
GABAergic terminals can be attributed to PV- or CCK-positive
interneurons, which are labeled by PV/synaptotagmin 2 and
CCK8/VGluT3/cannabinoid receptor 1 (CB1), respectively. We
found that markers for presynaptic terminals from CCK-positive
interneurons were virtually absent in CA1 pyramidal layer of DG
cKO mice (Fig. 4A–D,G, I,K). Still, as in control mice, CCK-
positive cell somata were occasionally observed in cKO CA1
pyramidal layer, and these were often covered with VGluT3-
positive boutons (Fig. 4A, arrowhead). Synaptotagmin 2 and PV
immunolabeling was still present in typical punctate distribution
in the pyramidal layer of cKO mice (Fig. 4A–D,H, J), demon-
strating the specific requirement of DG for formation of presyn-
aptic terminals from CCK-positive interneurons. Preferential
apposition of DG to CCK-positive interneuron terminals might
be expected from this finding. However, apposition of DG to
VGluT3 as well as to PV suggests no such distinction, at least at
the resolution of conventional confocal laser scanning micros-
copy (Fig. 4C, arrowheads). Still, as a percentage of presynaptic
immunofluorescence apposed to DG, VGluT3 showed more
complete overlap with DG, indicating that PV apposition to DG
might be caused by mere abundance of PV immunofluorescence
in the pyramidal layer (data not shown). Loss of CCK-positive
interneuron terminals extended from CA3 to CA1 (Fig. 4E). Sur-
prisingly, no corresponding reduction in vesicular GABA trans-
porter (VGAT) puncta was observed (Fig. 4F). To test whether
sprouting of PV-positive axons compensates for the loss of CCK-
positive terminals, the portion of VGAT-positive terminals con-
taining PV was assessed. No significant difference was found in
the fraction of VGAT puncta colocalized with PV between
genotypes (31.05
 2.05% for control vs 33.24
 1.57% for cKO,
t(8)  0.847, p  0.422, unpaired t test), suggesting that PV-
positive axon terminal sprouting does not account for the per-
sisting VGAT immunolabeling.
Despite the drastic loss of CCK-positive terminals, somata
exhibiting CCK immunofluorescence were observed in cKO hip-
pocampi (Fig. 4A). To characterize the distribution and abun-
dance of CCK-positive interneurons, sections of cKO and control
dorsal hippocampus were immunoperoxidase-stained and CCK-
positive cell density quantified using stereology. CCK-positive
cell somata in cKO mice were reduced to less than half the density
observed in control mice (816.77 
 28.38 mm3 vs 368.51 

4.88 mm3, t(8) 15.566, p	 0.001, unpaired t test). Along with
cell density, immunoperoxidase staining intensity of CCK-
positive cells was diminished in the CA1 to CA3 region in DG
cKO mice.
Because the DGC is prominently expressed by pyramidal cells in
the neocortex, it seemed likely that CCK-positive interneuron ter-
minals in neocortex are also compromised by loss of neuronal DG.
Indeed, CCK8 and CB1 immunolabeling was strongly reduced in
primary somatosensory cortex (S1) of DG cKO mice, whereas PV
staining was unchanged (apart from a minute difference in size; Fig.
5). VGluT3 puncta density was not decreased in neocortex of DG
cKO mice, in agreement with histological studies showing that
VGluT3 is present mostly in serotonergic fibers in this brain area
(Fig. 5B,G) (Scha¨fer et al., 2002). As in hippocampus, reduction of
CCK-positive terminals was not paralleled by a decrease of VGAT
puncta (Fig. 5A,E). Markers for CCK-positive terminals were re-
duced uniformly across all cortical layers and in all regions of the
neocortex that were examined (Fig. 5D).
Satz et al. (2010) have reported blunted long-term potentia-
tion in CA1 pyramidal cells of mice with NEX-Cre-mediated DG
ablation. To exclude that loss of CCK-positive interneuron ter-
minals represents compensatory changes to large glutamatergic
alterations, glutamatergic markers were examined as a proxy for
integrity of glutamatergic synapses (Fig. 6). Clustering of the
postsynaptic glutamatergic markers PSD-95 and bassoon did not
differ significantly between genotypes (Fig. 6A,B), and neither
did VGluT1 immunolabeling (Fig. 6C). Furthermore, the por-
tion of PSD-95 clusters apposed to VGluT1 was similar in both
genotypes (Fig. 6D).
Formation andmaintenance of CCK-positive basket cell
terminals require neuronal DG
DG expressed by pyramidal cells might have a function in synapse
formation or in guidance of a subset of axons, similar to its role in
4
(Figure legend continued.) in CA1 pyramidal cell layer. Cluster density and size are shown for
GABAAR1 (D),2 (F), and2 (H) subunits and for gephyrin (E) andNL2 (G). A decrease of1
subunit cluster size was accompanied by an increased2 subunit cluster density. I, Colocaliza-
tion of postsynaptic GABAergic markers was analyzed in cKO and control mice. Data are the
number of colocalized clusters as percentage of first mentioned marker. No significant differ-
ences in colocalizationwere found between genotypes. J, Clustering of synArfGEFwas analyzed
in CA1 pyramidal layer of DG cKO and control mice. Data points represent individual mice (for
statistical tests, see Table 2). **p	 0.01. ***p	 0.001.
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the spinal cord (Wright et al., 2012). Al-
ternatively, a function in maintenance
of synapses through continuous trans-
synaptic signaling is conceivable. If neu-
ronal DG is crucial for synapse formation
of CCK-positive terminals, these boutons
should be reduced to the same degree as in
adults at a time point right after initial
synaptogenesis. Following this reasoning,
we examined CCK-positive terminals of
21-day-old DG cKO and control mice in
CA1 pyramidal layer. Indeed, VGluT3
puncta were largely missing also at this
stage of development, whereas immuno-
staining of PV-positive terminals was not
significantly different between genotypes
(Fig. 7).
Although this finding indicates that
synapse formation of functional CCK-
positive terminals depends on DG, it does
not rule out a role for DG in maintaining
already formed connections. To assess
this putative function of DG in synapse
maintenance, we ablated DG long after
developmental synapse formation, by vi-
ral delivery of Cre to adult mice carrying
one or both floxed Dag1 alleles. AAV8-
CaMKII-mCherry-Cre was stereotacti-
cally injected unilaterally into the CA1
region and mice killed at 14, 28, 42, or 84 d
after injection (dpi; Fig. 8A,C). At 14 dpi,
Cre and mCherry fluorescence was clearly
visible (Fig. 8B). Loss of -DG staining at
28 dpi in homozygously floxed mice indi-
cated efficient recombination of loxP sites
(Fig. 8D). In heterozygously floxed mice,
only a moderate reduction of -DG label-
ing was observed, suggesting that one
wild-type allele is sufficient to sustain the
bulk of DG expression. Because dystro-
phin immunostaining revealed a reduc-
tion that mirrored -DG, and in addition
Figure 4. Neuronal dystroglycan ablation leads to specific loss of terminals from CCK-positive basket cells on hippocampal
pyramidal cells. A–D, Triple immunofluorescence labeling of presynaptic GABAergic markers in hippocampus CA1 area. A, In
pyramidal layer, markers labeling CCK-positive basket cell terminals (CCK8, VGluT3) are missing around pyramidal cell bodies but
are still present on CCK-positive cell somata occasionally observed near the pyramidal layer (arrows). These VGluT3-positive
4
boutons on CCK-positive somata were often immunopositive
for synaptotagmin 2 (Syt2). In the pyramidal layer, immuno-
staining for Syt2 remained in cKO mice. B1, B2, Separated
channels ofA (insets). C, PV immunolabeling in CA1 pyramidal
layer of DG cKO mice is indistinguishable from control. In CA1
pyramidal layer of control mice, the majority of-DG clusters
is either apposed toVGluT3 (arrow1)or PV (arrow2), but some
clusters are not apposed to eithermarker (arrow3). Aminority
of -DG clusters showed apposition to both VGluT3 and PV
(arrow 4). D, Along with CCK8 and VGluT3, CB1 staining is
strongly reduced inCA1pyramidal layer ofDG cKOmice.E, Loss
of CB1 immunofluorescence inDGcKOmicewasobserved from
CA1 to CA3. F–K, Quantification of presynaptic GABAergic
markers in CA1 pyramidal layer. No changes were found for
VGAT (F) and PV-positive basket cell markers (H, J) between
genotypes, but cluster density and size of markers of CCK-
positive basket cell terminals (G, I,K)were strongly reduced in
DG cKOmice. Data points represent individual mice (for statis-
tical tests, see Table 2). **p	 0.01. ***p	 0.001. SR, Stra-
tum radiatum; SP, stratum pyramidale.
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Figure 5. Neuronal dystroglycan ablation leads to specific loss of terminals from CCK-positive basket cells on pyramidal cells in neocortex.A–C, Triple immunofluorescence labeling of GABAergic
markers in layer 2/3 of primary somatosensory cortex (S1) of DG cKO and control mice. A, As in hippocampus, themajority of DG clusters is colocalized with presynaptic and postsynaptic GABAergic
markers in neocortex. B, Neocortical PV and VGluT3 immunolabeling is not affected by loss of neuronal DG. C, CCK8 and CB1 immunofluorescence is strongly reduced in neocortex of DG cKO mice.
Immunolabeling of synArfGEF showed clustered distribution anddid not differ betweengenotypes.D, Overviewof S1 of DG cKO and controlmice. Typical punctate CB1 immunofluorescencewas lost
across all layers of the cortex in DG cKO mice. E–I, Quantification of presynaptic GABAergic markers in S1 layer 2/3. VGAT and PV, and in contrast to hippocampus, also VGluT3 were not reduced in
density inmice lacking neuronal DG (E–G). However, CB1 and CCK8 showed a similar reduction as in hippocampus in DG cKOmice comparedwith controlmice (H, I). Data points represent individual
mice (for statistical tests, see Table 2). **p	 0.01. ***p	 0.001.
Fru¨h et al. • Dystroglycan Function at CCK-Positive Terminals J. Neurosci., October 5, 2016 • 36(40):10296–10313 • 10305
showed lower background, dystrophin was used to assess DGC
loss at subsequent time points (Fig. 8E–G). Examination of
VGluT3-positive terminals at 28 dpi in Cre-expressing regions of
CA1 pyramidal layer revealed a moderate but significant reduc-
tion of VGluT3 puncta density and size in homozygously floxed
mice compared with contralateral side compared with the ipsi-
lateral side of heterozygously floxed mice (Fig. 8H). VGluT3-
positive terminals in heterozygous mice were not affected.
Compromised VGluT3 immunolabeling was also found at later
time points in homozygous mice, and the effect became more
prominent with increased time after injection (Fig. 8 I, J). To-
gether, these results provide strong evidence for a role of DG both
in synapse formation and in retrograde trans-synaptic signaling
for maintenance of CCK-positive terminals.
Absence of CCK-positive basket cell terminals due to DG
ablation impacts pyramidal cell inhibitory input and
response to cholinergic activation
If axon terminals from CCK-positive basket cells are indeed
lost in DG ablated mice, this should be reflected by functional
changes of pyramidal cell inhibitory input. To test this hy-
pothesis, acute slices were prepared from adult DG cKO and
control brains and used for patch-clamp electrophysiological
recordings from morphologically identified CA1 pyramidal
cells (Fig. 9). With inhibitors of glutamatergic transmission
present in the bath, occurrence of sIPSCs was probed in both
genotypes. As anticipated from immunohistological changes,
sIPSC frequency in DG cKO was reduced to approximately
half of that in control slices (Fig. 9; 8.71 
 1.52 Hz vs 4.46 

0.90 Hz, t(26)  2.214, p  0.036, unpaired t test). Further-
more, DG cKO pyramidal cells were marked by a significantly
smaller sIPSC amplitude than that of control cells (61.49 

7.90 pA vs 39.18
 2.39 pA, t(26) 2.374, p 0.025, unpaired
t test). No significant differences were found between geno-
types in sIPSC rise and decay times (rise time 1.73
 0.09 ms vs
1.63
 0.12 ms, t(26) 0.664, p 0.512, unpaired t test; decay
time 14.84 
 0.64 ms vs 14.21 
 0.53 ms, t(26)  0.717, p 
0.480, unpaired t test).
The differences observed in baseline sIPSCs could be due to a
general reduction of inhibitory transmission instead of interneu-
Figure 6. Neuronal dystroglycan is not necessary for clustering of glutamatergic synaptic proteins. A, B, To assess integrity of glutamatergic postsynaptic structures, antibodies to PSD-95 and
bassoon were used and immunofluorescence quantified in stratum pyramidale and stratum radiatum. Cluster density and size were analyzed in stratum pyramidale and fluorescence intensity in
stratum radiatum. All parameters analyzed did not differ substantially between genotypes. C, VGluT1 was used as a marker of glutamatergic presynaptic terminals, and puncta density and size in
stratum pyramidale were quantified. No changes in VGluT1 puncta density and size were found between genotypes. D, PSD-95 apposition to VGluT1 was examined in stratum pyramidale and
represented as percent PSD-95 clusters apposed to VGluT1 puncta. The apposition of PSD-95 to VGluT1 did not differ between genotypes. Data points represent individual mice (for statistical tests,
see Table 2). *p	 0.05. ***p	 0.001.
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ron subtype-specific loss of terminals. To gain insight into the
origin of reduced inhibitory transmission in DG cKO pyramidal
cells, we examined the effect of the acetylcholine receptor agonist
CCh on inhibitory currents. In slices, CCh exposure leads to an
increase of perisomatic inhibitory transmission in pyramidal
cells, which is mediated by direct excitation of CCK-positive
interneurons (Nagode et al., 2014). Given that CB1 receptor-
containing terminals are required for increased inhibitory trans-
mission after application of CCh, this effect should be absent in
DG cKO mice if CCK-positive basket terminals are indeed non-
functional in these mice. CCh was bath-applied to DG cKO and
control acute slices from which sIPSCs were recorded in CA1
pyramidal cells. In control slices, CCh led to a robust increase in
sIPSC frequency within minutes after application (Fig. 10A–C;
frequency: 6.15
 1.45 Hz vs 10.53
 2.47 Hz, t(7)  3.522, p
0.010; amplitude: 63.36 
 8.84 pA vs 70.35 
 12.59 pA, t(7) 
0.943, p 0.377; paired t tests). However, no statistically signif-
icant effect of CCh was observed in DG cKO pyramidal cells (Fig.
10D–F; frequency: 3.45
 0.75 Hz vs 4.47
 1.56 Hz, t(6) 0.797,
p 0.456; amplitude: 45.70
 4.17 pA vs 53.03
 5.00 pA, t(6)
1.239, p  0.262; paired t tests). Together with the results from
baseline recordings and immunohistochemical analysis, these
findings strongly argue that functional connectivity between
CCK-containing basket cells and pyramidal cells is lost in DG-
ablated mice.
Persistence of CCK-positive terminals in DG T190M knock-in
mice suggests trans-synaptic DG function is independent of
neurexin binding
The intriguing finding that DG is required for formation and
maintenance of CCK-positive terminals calls for an assessment of
the clinical significance of this observation. In a subgroup of
dystroglycanopathies, intellectual disability, although severe, is
not accompanied by neuronal migration deficits (Godfrey et al.,
2007). Dag1 T190M knock-in mice are a model of one such form
of dystroglycanopathy and resemble the symptoms found in pa-
tients with the corresponding mutation (Dinc¸er et al., 2003; Hara
et al., 2011). Interestingly, this mutation abolishes binding of DG
to neurexin, a putative presynaptic DG binding partner. We com-
pared markers of CCK-positive terminals in CA1 pyramidal layer
of homozygous Dag1 T190M mice with wild-type mice (Fig. 11).
Surprisingly, both VGluT3 and CB1 puncta were indistinguish-
able between Dag1 T190M and wild-type mice. Weaker and
more diffuse labeling in Dag1 T190M mice using the -DG
glycosylation-specific antibody 11H6 confirmed that this muta-
tion affects glycosylation of neuronal DG (Fig. 11B). Apposition
of-DG to PV or VGluT3-positive terminals was not changed by
T190M mutation (Fig. 11E). Therefore, DG function for CCK-
positive terminals is likely neurexin-independent, which suggests
that a novel presynaptic receptor might be involved in this trans-
synaptic connection.
Figure 7. CCK-positive terminals are not established in the absence of neuronal dystroglycan. A, Triple immunofluorescence labeling of DG cKO and control CA1 pyramidal layer at postnatal day
21.B, C, Quantification of puncta density and size reveals loss of VGluT3 puncta in DG cKO tissue to the samedegree as in adultmice (B) but unchanged PV immunolabeling (C). Data points represent
individual mice (for statistical tests, see Table 2). ***p	 0.001.
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Figure 8. Maintenance of CCK-positive basket terminals requires dystroglycan. A, Overview of experimental design. Virus was stereotactically injected unilaterally into CA1 region in adult mice
heterozygous or homozygous for loxP sites flanking the Dag1 gene. B, After 14 dpi, Cre recombinase immunolabeling and mCherry fluorescence were clearly visible in pyramidal cell somata.
C, Example of the injection site at 28 dpi. Cre expression was mostly restricted to the CA1 pyramidal cell layer. VGluT3 and dystrophin or DG immunofluorescence (Figure legend continues.)
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Discussion
Our experiments have yielded five main findings about the syn-
aptic function of DG. Ablation of neuronal DG, which also
hindered synaptic clustering of dystrophin, led only to minor
changes in clustering of GABAergic PSD proteins. These altera-
tions might reflect compensatory changes to the massive pres-
ynaptic defects found in DG-deficient mice. Importantly, DG
synaptic function is interneuron subtype-specific because loss of
synaptic markers was restricted to CCK-expressing basket cell
terminals. Formation and maintenance of these synapses re-
quired neuronal DG, indicating that trans-synaptic signaling is
important both at the time of developmental synaptogenesis and
continuously during adulthood. Function of CCK-positive bas-
ket cell terminals was likely compromised along with specific
marker expression because loss of DG resulted in a reduced base-
line spontaneous inhibitory activity in pyramidal cells that could
not be increased by CCh. Finally, postphosphorylation glycosyl-
ation of DG is not necessary for CCK-positive synapse formation
because Dag1 T190M knock-in mice showed normal CCK-
positive terminals, suggesting that presynaptic receptors other
than neurexins might be involved in DG trans-synaptic function.
Postsynaptic GABAergic alterations ascribed to DGC deficits
may be secondary to innervation defects
Ablation of DG in primary hippocampal culture has revealed that
DG is not necessary for GABAergic synapse formation and for
clustering of main GABAergic PSD proteins, including GABAARs
(Le´vi et al., 2002). Yet, involvement of the DGC in clustering of
GABAergic postsynaptic proteins was supported by several lines
of evidence. Mdx mice, used as a DMD model because of their
lack of full-length dystrophin, were shown to have reduced
GABAAR (but not gephyrin) clustering in the hippocampus CA1
region (Knuesel et al., 1999). Overexpression of a shorter dystro-
phin construct in vivo rescued the decrease of GABAAR cluster
density and size, adding to the notion that dystrophin loss di-
rectly caused GABAAR clustering defects (Vaillend et al., 2010).
NL2 was shown to biochemically interact with dystrophin over
the intracellular synaptic scaffolding molecule S-SCAM (Sumita
et al., 2007). Furthermore, a functional connection between the
DGC and NL2 is suggested by the observation that, in GABAAR
2 subunit KO mice, NL2 clustering is only compromised in
dendritic but not in perisomatic areas (Panzanelli et al., 2011).
The modest increase in GABAAR2 subunit density and decrease
in GABAAR 1 subunit size found in the present study do not
correspond to the findings in mdx mice, in which both subunits
cluster less efficiently than in wild-type mice (Knuesel et al., 1999;
Vaillend et al., 2010). Rather, these alterations might reflect a
subunit composition change because GABAAR 2 subunit clus-
ters were not affected by ablation of DG (except for a minute
reduction in cluster size, which might be a reflection of reduced
GABAAR1 subunit cluster size). The finding that gephyrin clus-
tering was unchanged in DG cKO mice further supports the con-
clusion that overall clustering of synaptic GABAAR subunits was
not influenced by neuronal DG loss. The discrepancy between
our results and published data from mdx mice might be ex-
plained by different roles of dystrophin isoforms at the GABAe-
rgic PSD. Short dystrophin isoforms still present in the mdx
model might, by binding to DG, cause the reduction in synaptic
GABAAR clustering. It is worth noting that the 2 subunit of
GABAARs, which is localized preferentially at CCK-positive syn-
apses (Nyíri et al., 2001), does not require the DGC or CCK-
positive terminals for clustering. The DGC is thus likely involved
in targeting the 2 subunit to synapses apposed to CCK-positive
terminals, but clustering mechanisms seem to be DGC-
independent. NL2 clustering was intact in DG cKO mice, apart
4
(Figure legend continued.) was analyzed in the same sections.D, Inmice containing homozy-
gously floxed Dag1,-DG immunostainingwasmarkedly reduced in CA1 pyramidal layer at 28
dpi. Heterozygous mice showed a moderate reduction in-DG immunofluorescence. E–G, As
observed for -DG, Cre expression led to loss of dystrophin in homozygously floxed mice,
whereas only a slight decrease was observed in heterozygous mice. Reduction of dystrophin
labeling was similar at 28 dpi (E), 42 dpi (F), and 84 dpi (G). H–J, Representative example
images and quantifications of VGluT3 immunostaining in CA1 pyramidal layer at 28 dpi (H), 42
dpi (I), and 84 dpi (J). Ipsilateral VGluT3 size and density in homozygously floxed mice were
significantly reduced compared with both contralateral side and ipsilateral side of heterozy-
gously floxedmice.With increased time after injection, this reduction of VGluT3 puncta became
more prominent. Data points represent individual mice (for statistical tests, see Table 3). *p	
0.05. **p	 0.01. ***p	 0.001.
Figure 9. Frequency and amplitude of sIPSCs are reduced in dystroglycan cKO pyramidal cells. A, Position of the recording pipette in the hippocampal CA1 region (left, 4), and an example of
a typical CA1 pyramidal cell identified using LED illumination (AlexaFluor-488, right, 40).B, Representative example traces ofwhole-cell sIPSC recordings from controlmice (left) andDG cKOmice
(right). Average sIPSCs are shownabove the traces. C, Cumulative frequency plot of IEIs of sIPSCs from control (blue line) andDG cKO cell (red line) from the traces inB (left) and cumulative frequency
plot of sIPSC amplitudes from the same cells (right). D, Comparison of average sIPSC frequency and amplitude between control and DG cKO slices. DG cKO mice exhibit significantly lower sIPSC
frequency and amplitude than control mice. Data points represent individual cells. *p	 0.05.
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from a slight decrease in cluster size. Therefore, the notion of the
DGC as an obligatory stabilizer of postsynaptic NL2 clustering by
mutual interaction with S-SCAM does not hold. Similarly, a role
for the DGC in clustering the dystrophin-interacting protein sy-
nArfGEF at GABAergic synapses was suggested (Fukaya et al.,
2011). Not excluding a contribution of the DGC to synArfGEF
function by clustering additional signaling proteins, synArfGEF
does not rely on the DGC to form clustered, presumably synaptic
structures.
In the light of the dramatic changes in GABAergic innervation
due to DG loss, an indirect presynaptic contribution to reduced
postsynaptic clustering in dystrophin-deficient models should be
considered. This hypothesis is supported also by the finding of re-
duced CCK-positive basket cell markers in mdx mice, suggesting
that dystrophin plays a part in trans-synaptic signaling (Krasowska
et al., 2014). The role of dystrophin in clustering signaling proteins at
CCK-positive terminals is still unexplored but might include retro-
grade signaling by nitric oxide synthase. Resolution of conventional
confocal laser scanning microscopy is not sufficient to conclusively
answer whether the DGC is restricted to synapses from CCK-
positive basket cells. Although apposition of DG to PV- and CCK-
positive terminals was found with approximately equal frequency
(Fig. 11E), the percentage of CCK-positive terminals apposed to DG
was higher than that of PV-positive terminals (data not shown; Figs.
4C, 7A). Therefore, it seems likely that the DGC localizes preferen-
tially postsynaptic to CCK-positive terminals to regulate synapse
formation and function.
Figure10. Dystroglycan is necessary for CCh-induced increase of inhibitory currents in pyramidal cells. A, Representative example traces of sIPSC recordings before (baseline, left trace)
and after the application of CCh (right) in control mice. Average sIPSCs are shown above the traces. B, Cumulative frequency plots of IEIs and amplitudes of sIPSCs from traces
in A. C, Comparison of average sIPSC frequency and amplitude before and after application of CCh in control slices. Application of CCh resulted in typical increase of IPSC frequency in
control pyramidal cells, but amplitude was not affected by CCh. D, Representative example traces of sIPSC recordings before (baseline, left trace) and after the application of CCh (right
trace) in DG cKO mice. Average sIPSCs are shown above the traces. E, Cumulative frequency plots of IEIs and amplitudes of sIPSCs from traces in D. F, Comparison of average sIPSC
frequency and amplitude before and after application of CCh in DG cKO slices. In contrast to control slices, application of CCh did not lead to a significant increase of sIPSC frequency in DG
cKO pyramidal cells. Data points represent individual cells. **p	 0.01.
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Basket cell type specificity of DG function implies specificity
of trans-synaptic interaction with presynaptic binding
partner
The selective dependence of the CCK-containing subtype of bas-
ket cells on neuronal DG for innervating target cells is a major
finding of our study and has far-reaching implications. The DGC
indeed acts as a trans-synaptic complex in central synapses, sug-
gesting that presynaptic, rather than extracellular, binding part-
ners enable DGC function in this context. Any such presynaptic
adhesion molecule would have to be specifically localized at
CCK-positive terminals. Interestingly, differential splicing of
neurexins in PV- and CCK-expressing basket cells was recently
reported (Fuccillo et al., 2015). Transcripts lacking neurexin1
alternative splice inserts 2 and 4, which prevent -DG binding to
LSM domains 2 and 6, respectively, were only found in CCK-
positive basket cells (Sugita et al., 2001; Reissner et al., 2014;
Fuccillo et al., 2015). This neurexin isoform specificity of basket
cell subtypes would provide a mechanism for selective depen-
dence of CCK-positive basket terminals on DG. However, we
found terminals from CCK-positive basket cells to be intact in
Dag1 T190M knock-in mice. DG containing the T190M muta-
tion was found to lose neurexin binding capacity (Hara et al.,
2011). This finding thus suggests that a novel presynaptic DG
binding partner might be specifically localized at CCK-positive
terminals. But because the diversity of neurexin isoforms was not
considered in DG T190M binding assays, the possibility of a spe-
cific neurexin-DG trans-synaptic complex at CCK-positive ter-
minals remains.
Continuous trans-synaptic signaling required for
maintenance of CCK-positive terminals might reflect novel
plasticity mechanism
Stopping trans-synaptic signaling mediated by the DGC by ablat-
ing DG in adulthood led to a decrease of CCK-positive terminals
within weeks. This unexpected result implies that DG function
goes beyond a potential role in validating newly formed synapses
from CCK-positive basket cells. In addition to clustering signal-
ing molecules at these synapses, our findings open the possibility
that the DGC, by forming a trans-synaptic complex, is a direct
target to regulate abundance of CCK-positive terminals. -DG is
a substrate of MMP-9 in a neuronal activity-dependent manner
(Yamada et al., 2001; Kaczmarek et al., 2002; Michaluk et al.,
Figure 11. Neurexin and laminin binding of -dystroglycan is not essential for formation of CCK-positive basket terminals on pyramidal cells. A, B, Triple immunofluorescence labeling of
GABAergicmarkers in CA1 pyramidal layer ofDag1 T190Mandwild-typemice.A, Antibody to-DG revealed typical clustered distribution inDag1 T190Mmice. VGluT3 and PV immunofluorescence
was indistinguishable between genotypes. B, Intensity of DG clusters was markedly reduced and background staining increased using the-DG glycosylation-specific antibody 11H6, confirming
glycosylation deficits of synaptic DG in T190Mmice. CB1 and GABAAR2 subunit immunofluorescence was indistinguishable between genotypes. C,D, Quantification of density and size of VGluT3
(C) and CB1 (D) puncta in CA1 pyramidal layer of Dag1 T190M andwild-typemice. Density and size of puncta did not differ significantly between genotypes. E, Quantification of-DG apposition to
PV and/or VGluT3 in CA1 pyramidal layer. Data are number of -DG clusters apposed to PV or VGluT3 or both (triple colocalized) as percentage of total -DG clusters. Apposition of -DG to
presynaptic markers did not differ significantly between genotypes. Data points represent individual mice (for statistical tests, see Table 2).
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2007). Cleavage of DG might therefore represent a physiological
interneuron subtype-specific plasticity mechanism. In striking
agreement with this hypothesis, CCK-positive terminals are se-
lectively lost in a model of temporal lobe epilepsy (Wyeth et al.,
2010).
Decreased inhibitory input to pyramidal cells in DG-ablated
cells confirms functional significance of DG signaling for
CCK-positive terminals
The possibility that loss of CCK-specific markers in DG cKO mice
is only due to inability of terminals to differentiate was ruled out
by the finding that DG-ablated pyramidal cells receive reduced
inhibitory drive. Along with sIPSC frequency, amplitude was
markedly reduced, possibly reflecting mistargeting of GABAARs
in the absence of the DGC. Genesis of CCh-induced increase of
inhibitory currents is not fully understood but involves Gad2-
positive rather than PV-positive interneurons in the CA1 region
(Nagode et al., 2014). Because the group of Gad2-expressing in-
terneurons includes CCK-positive basket cells and CCh-induced
currents are sensitive to depolarization-induced suppression of
inhibition, our results add to the notion that CCK-positive basket
cells play a crucial role in CCh-induced activity. Activity patterns
elicited by CCh correlate with behaviorally relevant  oscillations.
Mechanisms of  oscillation generation should thus be consid-
ered in future investigations of the etiology of intellectual disabil-
ity associated with muscular dystrophies.
In conclusion, our investigation of the role of neuronal DG in
GABAergic synapses has revealed a surprising interneuron type-
specific function of DG in trans-synaptic signaling. It has shown
that GABAergic postsynaptic diversity is functionally related to
interneuron subtype heterogeneity and supports the emerging
notion of a cell type-specific molecular code of synapse forma-
tion. Future studies will have to further characterize signaling
and plasticity enabled by the DGC and delineate its behavioral
consequences. Taking the interneuron-specific role of DG into
consideration will help elucidate the mechanisms underlying in-
tellectual disability observed in muscular dystrophies without de-
velopmental brain malformations.
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